"L’hôpital Edouard Herriot dispose de services d’excellence dans quasiment toutes les spécialités médicales et chirurgicales, avec des services phares : la chirurgie d’urgence, la chirurgie orthopédique, les transplantations et l’immunologie, la rhumatologie, l’hépato-gastroentérologie, la médecine et la chirurgie vasculaires, la néphrologie-dialyse, la médecine du vieillissement, le traitement des grands brulés…"

During the past decade, Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" #1 collaborator was "ARC Foundation for Cancer Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" are "Autosomal Dominant Hypocalcemia" (1 trials), "Colorectal Cancer (CRC)" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Lynch Syndrome" (1 trials) and "Non-Transfusion-dependent Alpha-Thalassemia" (1 trials). Many other conditions were trialed in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mitapivat" (2 trials), "Placebo Matching Mitapivat" (2 trials), "Colonoscopy" (1 trials), "Evolocumab" (1 trials) and "Panitumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Universitaire de Lyon - Hopital Edouard Herriot, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".